Capital Com MENA Securities Trading LLC is regulated by the Capital Market Authority.
Open platformOpen platform

Haemonetics Raises Fiscal 2027 Revenue Growth Forecast to 8%-11%

By Public Technologies
  • Haemonetics raised fiscal 2027 reported revenue growth guidance to 8%-11% from 5%-8%.
  • Organic revenue growth is now forecast at 6%-9%, up from 4%-7%.
  • Adjusted operating margin expansion was lowered to 0-50 basis points year over year from 50-100 basis points.
  • Free cash flow conversion is expected to exceed 80%, versus about 80% previously.
  • Second-quarter revenue rose 9.3% to $357.8 million; adjusted earnings per share increased 6% to $1.35.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Haemonetics Corporation published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.